NOV 03, 2016 01:30 PM PDT

Development of a novel method to measure circulating 1,25-Dihydroxyvitamin D in Human Serum and plasma

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Chief Scientific Officer, VP, DIASORIN Inc.
    Biography
      Fabrizio Bonelli is Chief Scientific Officer of the DIASORIN group. He has been working in the R&D Department of DIASORIN for 29 years, previously at the Italian site and since 2010 at the US site in Minnesota. Prior to joining DIASORIN he was a postdoctoral fellow at the National Cancer Institute in Bethesda, MD, conducting research in the field of cellular carcinogenesis and tumor promotion.

    Abstract:

    We describe a novel method to measure 1,25(OH)2D. Briefly, this method was built on four pillars:  (1) the nuclear vitamin D receptor (VDR)`s ligand binding domain (LBD) as a capture molecule; (2) reaction conditions which favor binding of 1,25(OH)2D to LBD and not the vitamin D binding protein: (3) exploitation of LBD’s bound ligand induced conformational change; and (4) a Monoclonal Antibody (Mab) specific to the unique LBD-1,25(OH)2D complex conformation. This Mab, which comprises the “core” component of the method, leveraged and applied seminal observations previously reported by K. Singarapu et al (Biochemistry 2011;50(51):11025-33). Solution NMR of the LBD showed spectra differences with and without ligand. These differences prompted the idea that these different conformations could be used to elicit specific immunological responses against each form, thus enabling specific discrimination by immunological methods.
    The enrichment free, non-competitive format of this method has been found to be superior to all previous immunoassays and LC-MS/MS assay methods, due to its enhanced precision and accuracy. The accuracy and precision of this new REceptor-Assisted Chemiluminiscent (REACH) assay has been independently validated and has exhibited exemplary performance in the Vitamin D External Quality Assurance Scheme (DEQAS). This technology will allow studies previously inhibited by large sample requirements to proceed by providing significantly improved accuracy over anything offered in the past. 
     


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    Loading Comments...
    Show Resources